ALDH7A1 and glioblastoma: At a concentration of 100 μM, nearly all the tested PDE inhibitors, apart from vinpocetine, irsogladine and sildenafil, significantly increased cAMP levels in at least one of the three glioblastoma lines (Figure 3A).